Biodesix (BDSX) Stock Statistics & Valuation Metrics

Biodesix has a market cap or net worth of $151.63M. The enterprise value is $159.30M.

Biodesix has 10,108,580 shares outstanding. The number of shares has decreased by -2.65% in one year.

Biodesix’s return on equity (ROE) is 14.31 and return on invested capital (ROIC) is -39.03%.

The current PE Ratio of Biodesix is ―. Biodesix’s PEG ratio is 0.05.

In the last 12 months, Biodesix had revenue of 88.50M and earned -35.27M in profits. Earnings per share was -4.67.

In the last 12 months, operating cash flow was -23.27M and capital expenditures -385.00K, giving a free cash flow of -23.66M billion.

Biodesix pays an annual dividend of ―, resulting in a dividend yield of ―

Biodesix upcoming earnings date is Aug 12, 2026, After Close (Confirmed).

Biodesix as a current ratio of 1.86, with Debt / Equity ratio of 784.17%

In the past 12 months, Biodesix has paid 0.00 in taxes.

Biodesix EV to EBITDA ratio is -4.81, with an EV/FCF ratio of -4.44.

Biodesix has $18.99M in cash and marketable securities with $72.85M in debt, giving a net cash position of -$53.87M billion.

Gross margin is 59.86%, with operating margin of -31.50%, and net profit margin of -39.85%.

The average price target for Biodesix is $30.67, which is 11.43% higher than the current price. The consensus rating is Strong Buy